ZHU Shengyi , TONG Yuling , ZHAO Yi , LÜ Haipeng , LIN Zhi , SHEN Guoli , SUN Ting , SONG Zhenya . Effect of Pu-erh Tea on Long Chain Fatty Acid Metabolism and Expression of Tight Junction Proteins in the Rat Model of Non-alcoholic Fatty Liver Disease[J]. Journal of Tea Science, 2016 , 36(3) : 237 -244 . DOI: 10.13305/j.cnki.jts.2016.03.002

[1] Wieland AC, Mettler P, McDermott MT, et al. Low awareness of nonalcoholic fatty liver disease among patients at high metabolic risk[J]. J Clin Gastroenterol, 2015, 49(1): e6-e10.
[2] Ogawa Y, Imajo K, Yoneda M, et al.Pathophysiology of NAsh/NAFLD associated with high levels of serum triglycerides[J]. Nihon Rinsho, 2013, 71(9): 1623-1629.
[3] Glatz JF, Luiken JJ, Bonen A.Membrane fatty acid transporters as regulators of lipid metabolism: implications for metabolic disease[J]. Physiol Rev, 2010, 90(1): 367-417.
[4] Miele L, Valenza V, La Torre G, et al.Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease[J]. Hepatology, 2009, 49(6): 1877-1887.
[5] Park EJ, Thomson AB, Clandinin MT.Protection of intestinal occludin tight junction protein by dietary gangliosides in lipopolysaccharide-induced acute inflammation[J]. J Pediatr Gastroenterol Nutr, 2010, 50(3): 321-328.
[6] Reid AE.Nonalcoholic steatohepatitis[J]. Gastroenterology, 2001, 121(3): 710-723.
[7] 陈宗懋, 甄永苏. 茶叶的保健功能 [M]. 北京: 科学出版社, 2014.
[8] Dulloo AG, Duret C, Rohrer D, et al.Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans[J]. Am J Clin Nutr, 1999, 70(6): 1040-1045.
[9] Chen ZM, Lin Z.Tea and human health: biomedical functions of tea active components and current issues[J]. J Zhejiang Univ Sci B, 2015, 16(2): 87-102.
[10] Cao ZH, Gu DH, Lin QY, et al.Effect of pu-erh tea on body fat and lipid profiles in rats with diet-induced obesity[J]. Phytother Res, 2011, 25(2): 234-238.
[11] Hou Y, Shao W, Xiao R, et al.Pu-erh tea aqueous extracts lower atherosclerotic risk factors in a rat hyperlipidemia model[J]. Exp Gerontol, 2009, 44(6/7): 434-439.
[12] Lee LK, Foo K Y.Recent advances on the beneficial use and health implications of Pu-Erh tea[J]. Food Research International, 2013, 53: 619-628.
[13] Kuo KL, Weng MS, Chiang CT, et al.Comparative studies on the hypolipidemic and growth suppressive effects of oolong, black, pu-erh, and green tea leaves in rats[J]. J Agric Food Chem, 2005, 53(2): 480-489.
[14] 肖凯, 朱晟易, 童钰铃. 普洱茶水提取物对大鼠非酒精性脂肪性肝病的干预作用[J]. 第三军医大学学报, 2013: 35(18): 1992-1995.
[15] Han X, Fink MP, Yang R, et al.Increased iNOS activity is essential for intestinal epithelial tight junction dysfunction in endotoxemic mice[J]. Shock, 2004, 21(3): 261-270.
[16] Harhaj NS, Antonetti DA.Regulation of tight junctions and loss of barrier function in pathophysiology[J]. Int J Biochem Cell Biol, 2004, 36(7): 1206-1237.
[17] 许腊梅,孙丹莉,张予蜀. 紧密连接蛋白Occludin在非酒精性脂肪肝大鼠肠上皮细胞中的表达及其与TNF-α的关系[J]. 世界华人消化杂志, 2010, 18(10): 981-986.
[18] Fanning AS, Jameson BJ, Jesaitis LA, et al.The tight junction protein ZO-1 establishes a link between the transmembrane protein occludin and the actin cytoskeleton[J]. J Biol Chem, 1998, 273(45): 29745-29753.
[19] Liang Y, Zhang L.A study on chemical estimation of pu-erh tea quality[J]. Journal of the science of food agriculture, 2005, 95: 286-292.
[20] Zhou ZH, Zhang YJ, Xu M, et al.Puerins A and B, two new 8-C substituted flavan-3-ols from Pu-er tea[J]. J Agric Food Chem, 2005, 53(22): 8614-8617.
[21] Yang DJ, Hwang LS.Study on the conversion of three natural statins from lactone forms to their corresponding hydroxy acid forms and their determination in Pu-Erh tea[J]. J Chromatogr A, 2006, 1119(1/2): 277-284.
[22] 吕海鹏, 林智, 谷记平, 等. 普洱茶中的没食子酸研究[J]. 茶叶科学, 2007, 27(2): 104-110.
[23] Lv H, Zhu Y, Tan J, et al.Bioactive compounds from Pu-erh tea with therapy for hyperlipidaemia[J]. Journal of Functional Foods, 2015, 19: 194-203.
[24] 吕海鹏, 谷记平, 林智, 等. 普洱茶的化学成分及生物活性研究进展[J]. 茶叶科学, 2007, 27(1): 8-18.
[25] 东方, 杨子银, 何普明, 等. 普洱茶抗氧化活性成分的LC-MS分析[J]. 中国食品学报, 2008, 8(2):133-141.